Trials / Completed
CompletedNCT01403077
480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions
A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- 480 Biomedical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an initial evaluation of the 480 Biomedical Bioresorbable Scaffold System for the treatment of subjects with de novo native superficial femoral artery lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 480 Biomedical Bioresorbable Scaffold System | 480 Biomedical Bioresorbable Scaffold System |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2014-03-01
- Completion
- 2015-10-01
- First posted
- 2011-07-27
- Last updated
- 2019-09-06
Locations
6 sites across 4 countries: Australia, Austria, Germany, New Zealand
Source: ClinicalTrials.gov record NCT01403077. Inclusion in this directory is not an endorsement.